January 22, 2025 - 03:09

In a significant move within the healthcare sector, BrightSpring Health Services has announced the divestiture of its ResCare Community Living business to Sevita for a substantial $835 million. This strategic decision reflects BrightSpring's commitment to streamline its operations and focus on its core service areas, enhancing its overall business model.
ResCare Community Living has been a vital part of BrightSpring's portfolio, providing essential services to individuals with intellectual and developmental disabilities. The sale to Sevita, a leading provider of specialized health services, is expected to create new opportunities for growth and innovation in the delivery of community living and support services.
The transaction is anticipated to close in the coming months, pending regulatory approvals. Both companies express confidence that the transition will be smooth and beneficial for the clients and communities they serve. Stakeholders are optimistic about the potential positive impact on service quality and accessibility in the community living sector following this acquisition.
March 31, 2026 - 08:40
SF Supervisor Jackie Fielder on leave due to mental health condition; her staff set to take overSan Francisco Supervisor Jackie Fielder is taking a temporary leave of absence from her official duties to address a mental health condition, her office confirmed this week. The announcement...
March 30, 2026 - 19:56
CVS Health puts creative and media in reviewCVS Health has launched a comprehensive review of its creative and media agency partnerships, a significant move that puts its substantial advertising account under scrutiny. This decision comes as...
March 30, 2026 - 15:51
New £1.5m research facility plan for New Cross HospitalA major £1.5 million investment is set to establish a new clinical research facility at New Cross Hospital, a move heralded by NHS leaders as a significant advancement for patient care, medical...
March 29, 2026 - 18:52
Makers of dietary supplements push the FDA to allow peptides and other new ingredientsThe dietary supplement industry is actively urging the U.S. Food and Drug Administration to modernize its regulatory approach to allow novel ingredients, including peptides and other compounds,...